arXiv · 2207.05671
Inferring sources of substandard and falsified products in pharmaceutical supply chains
Abstract
Substandard and falsified pharmaceuticals, prevalent in low- and middle-income countries, substantially increase levels of morbidity, mortality and drug resistance. Regulatory agencies combat this problem using post-market surveillance by collecting and testing samples where consumers purchase products. Existing analysis tools for post-market surveillance data focus attention on the locations of positive samples. This paper looks to expand such analysis through underutilized supply-chain information to provide inference on sources of substandard and falsified products. We first establish the presence of unidentifiability issues when integrating this supply-chain information with surveillance data. We then develop a Bayesian methodology for evaluating substandard and falsified sources that extracts utility from supply-chain information and mitigates unidentifiability while accounting for multiple sources of uncertainty. Using de-identified surveillance data, we show the proposed methodology to be effective in providing valuable inference.
Explore related subjects
Keep this discovery
Eugene Wickett, Matthew Plumlee, Karen Smilowitz, Souly Phanouvong, Victor Pribluda. 2022-07-12. Inferring sources of substandard and falsified products in pharmaceutical supply chains. https://doi.org/10.1080/24725854.2023.2174277
Cite the original work for its findings. Save a collection to share your selection of sources.